Editorial illustration for Qure.ai Unveils AI Diagnostic Tools to Detect TB and Lung Conditions
AI Diagnostics Breakthrough: Qure.ai Tackles TB Detection
Qure.ai launches AI tools qXR and qER to spot TB, lung nodules, hemorrhages
Qure.ai is launching two AI tools to parse medical scans faster. Its qXR software scrutinizes chest X-rays for tuberculosis and lung nodules. Separately, qER reviews head CTs to spot brain hemorrhages. The Mumbai-based company aims to deploy this dual system across 10,000 hospitals.
Qure.ai Qure.ai builds AI-powered diagnostic tools for medical imaging, including chest X-rays (qXR) and head CT scans (qER), to detect conditions like tuberculosis, lung nodules and haemorrhages. Their deep learning models speed up diagnosis by triaging critical cases in real time, reducing radiologists' workload. Recently, Qure.ai announced plans to expand to 10,000 hospitals in the coming years.
SigTuple SigTuple combines robotics and AI via its AI100 platform to digitise microscope slides, including blood smears and urine, and analyse them. Their AI models classify different cell types, detect morphological anomalies and flag abnormalities. The AI100 product is FDA 510(k) approved, and SigTuple holds multiple patents on its AI-based screening tools.
The immediate strategy is triage. A flagged brain bleed from qER jumps the radiologist's queue. Over in pathology, SigTuple’s FDA-cleared AI100 platform does the same, scanning digitized blood smears.
This isn't about replacing experts but managing crushing workloads. Qure.ai’s vast 10,000-hospital target signals a pivot: the tech is proven. Now comes the hard part of installation.
Related Reading
Business & Startups Nordic pilot adds Gemini for Education, NotebookLM to boost AI literacy
Business & Startups Kling launches Video O1, all-in-one model with MVL bridge using transformer
Business & Startups DeepSeek Seeks More Capital Weeks After USD 7B Funding Round
From Archives TCS launches AI platform for trial oversight as India's AI use rises to 86% from 65%
From Archives Google targets 1000x AI compute rise in five years with new chips, DeepMind aid
Common Questions Answered
How do Qure.ai's AI diagnostic tools improve tuberculosis detection?
Qure.ai's AI-powered tools like qXR use deep learning models to rapidly analyze chest X-rays and triage critical TB cases in real time. These tools can help radiologists quickly identify urgent medical conditions, potentially reducing the time between imaging and diagnosis.
What medical imaging platforms does Qure.ai currently offer?
Qure.ai provides two primary AI diagnostic tools: qXR for chest X-ray analysis and qER for head CT scan interpretation. These platforms are designed to detect conditions like tuberculosis, lung nodules, and hemorrhages, helping to speed up medical diagnostics and reduce radiologists' workload.
What are Qure.ai's expansion plans for their AI diagnostic technology?
Qure.ai has announced plans to expand its AI diagnostic tools to 10,000 hospitals in the coming years. This ambitious goal reflects the company's commitment to transforming medical imaging through artificial intelligence and improving disease detection speed and accuracy.
Further Reading
- Qure.ai's 2025 Breakthrough in AI Diagnostics — Innovation Library
- Qure.ai increases TB detection, while saving costs, shows evaluation in India — Qure.ai Newsroom
- Qure.ai Partners With Microsoft to Increase Access to Its Lung Cancer Detection and Management Suite in the U.S. — BusinessWire
- Qure.ai Earns 19th FDA Clearance for Neurocritical AI in U.S — Qure.ai Newsroom
- AI-Driven Chest X-Ray Tool Boosts Lung Cancer Detection — Qure.ai Newsroom
